04:17 PM EDT, 09/12/2025 (MT Newswires) -- W. Michael Flanagan, Chief Scientific Officer, on September 11, 2025, sold 20,000 shares in Avidity Biosciences ( RNA ) for $778,702. Following the Form 4 filing with the SEC, Flanagan has control over a total of 80,195 common shares of the company, with 80,195 shares held directly.

SEC Filing:

https://www.sec.gov/Archives/edgar/data/1599901/000159990125000184/xslF345X05/wk-form4_1757707665.xml